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Objective: To assemble a biohybrid patch consisting of a large (5 cm X 5 cm) elastomer 
scaffold whose pores are filled with a self-assembling peptide (SAP) gel entrapping 
adipose stem cells (ASCs), to be used in a big animal model of myocardial infarction. 
The study focuses on the way to determine optimal procedures for incorporating the 
SAP solution and the cells in the patch in order to ensure cell colonization and a 
homogeneous cell distribution in the construct before implantation. The problems 
associated with the scale-up of the different procedures raised by the large size of the 
construct are discussed. 
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Materials and methods: Experiments were performed to settle different alternatives: 
incorporation of the SAP gel prior to cell seeding or simultaneous SAP-and-cells 
loading of the scaffold; surface seeding of cells or cell injection into the scaffold’s 
pores; helping the seeded cells to disseminate throughout the scaffold prior to 
incubation by gentle shaking or by centrifugation. Immunocytochemistry techniques 
and confocal and scanning electron microscopies were employed in order to analyze and 
quantify the cell invasion and early distribution. Observed cell concentration and 
uniformity throughout the patch were taken as the indicators to settle the different 
alternative procedures. 
Results: The peptide pre-loaded scaffold, seeded internally and smoothly shaken before 
incubation yielded the best results in terms of greater cell density and the most uniform 
distribution after 24 h of culture compared with the other methods. These procedures 
could be translated to obtain large biohybrid  patches with success. 
Conclusions: The results obtained after the different seeding methods permitted to 
establish an effective protocol for the assembly of large scaffold + SAPs gel + cells 
biohybrids for their subsequent implantation onto the infarcted myocardium of a 
preclinical big animal model progressing for clinical translation. 
Keywords: scaffold, self-assembling peptide, cell seeding, myocardial patch, myocardial 









Adult human hearts are able to functionally regenerate after cardiac infarction [1, 2] but 
this capacity seems limited when large areas of cardiac tissue are involved, resulting in 
substantial loss of ventricular mass, vascularization and contractibility. Proposed 
strategies to repair damaged cardiac tissue include cell transplantation directly at the 
injured site, or tissue engineering techniques to induce the regeneration of injured native 
tissue. Cell types investigated include cardiac stem cells, skeletal myoblasts, stem cells 
from bone marrow or mesenchymal stem cells from adipose tissue, and endothelial 
progenitor cells, among others, usually resulting in an improvement of heart contraction 
by paracryne effects (secretion of cytokines), increase of wall thickness and micro-
vessel density (neovascularization) [3-6]. The main results reported with these 
procedures are however limited, not producing a complete restoration of the contractile 
function [7], owing to a poor cell retention and graft viability in the target site. Besides, 
a significant number of cells (more than 90%) die within the first days post-
transplantation or disseminate to other tissues. A possible solution would be to 
encapsulate the transplanted cells in an injectable gel, but this has the drawback of the 
low mechanical properties of gels, which difficults their handling, localization and 
retention on a damaged moving tissue. 
Alternative tissue engineering strategies [8, 9] combine cells with three-dimensional 
scaffolds or patches that host them and improve their survival, induce the formation of 
new blood vessels and extracellular matrix and at the same time mechanically assist the 
host tissue. The polymers employed to date to obtain scaffolds include collagen, gelatin, 
fibrin, hyaluronic acid and alginate [10-13] of natural origin, or the synthetic polylactide 
acid (PLA), polylactide-co-glycolic acid (PLGA), polycaprolactone (PCL), 
poly(ethylene glycol) (PEG), polypropylene (PP) and poly(glycerol sebacate) (PGS), 
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with different architectures and combined with a variety of cells [14-17]. As an 
example, Chachques et al. [18] implanted collagen sponges seeded with bone marrow 
cells onto the post-ischemic myocardial scar of a series of patients in a clinical 
feasibility study and observed an increase of the thickness of the infarct scar as well as a 
normalization of the cardiac wall stress. The main limitation of those scaffolds was the 
low mechanical characteristics of the materials employed to engineer the myocardial 
tissue and a too fast and complete bio-resorption of the material at mid-term. 
The concept of the 7
th
 FP project RECATABI, where this study is framed, is a biohybrid 
cardiac patch consisting in an elastomer polymer scaffold whose pores are filled with 
the self-assembling peptide (SAP) hydrogel RAD16-I, which encapsulates adipose-
tissue derived stem cells (ASCs). A first series of these patches employed poly(ethyl 
acrylate), PEA, as matrix to develop scaffolds with interconnected spherical pores; this 
polymer is an elastomer compatible with the myocardial tissue in terms of mechanical 
properties, is easy to process, and has excellent biological performance [19].  
SAPs are resorbable nanomaterials that mimic the structure of the extracellular matrix, 
promoting and modulating cell functions such as adhesion, proliferation and migration. 
Thanks to these properties, they have been used for a variety of applications in vitro 
with different types of cells (osteoblasts, embryonic stem cells, adult neural stem cells, 
endothelial cells,…) [20-22] and for regenerative strategies in animal models [23-26]. 
One commonly employed SAP, RAD16-I [18-20], is a hydrogel consisting of simple 
repeated sequences of RADA amino acids with alternating hydrophobic and hydrophilic 
lateral groups. They are injectable in aqueous solution, and form percolating β–sheet 
nanofibers when exposed to a salt solution or physiological media [21, 27, 28]. At low 
concentrations (0.15%-0.25%) the gel is soft and fragile, resulting in a poor 
manageability; on the contrary, at an elevated concentration (from 0.5 to 1%) the gel 
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becomes tough and impedes an adequate cellular ingrowth [21]. In the present proposal, 
the elastomer scaffold membrane provides the three-dimensional context and the 
mechanical integrity, whereas the peptide gel RAD16-I filling the scaffold’s pores is 
expected to act as an encapsulating medium for the cells, improving their survival and 
retaining them inside the membrane, allowing permeability to cellular metabolites and 
wastes, and likely improving vascularization throughout the scaffold. 
ASCs are a convenient cell source for cardiac regenerative purposes since they can be 
easily harvested from the patient, have an elevated proliferation rate in vitro and are 
non-immunogenic; besides, some studies and clinical trials have demonstrated their 
potential to improve ventricular function [29-32], which could lead to their use for 
cardiac clinical application [33,34]. Since the direct cell graft into infarcted myocardium 
has had poor results, with a rapid dissemination of cells to other sites and a low rate of 
cell survival of the effectively engrafted cells [35], the transplantation of the cells inside 
a physical support may help improve over those results: the scaffold can cover the 
damaged area, can protect the grafted cells by offering a cellular niche and thus prolong 
their survival and paracryne effect, and impede their migration from the site of interest. 
An increased localized activity of the cells could lead to wall thickening and 
neovasculogenesis, eventually improving the heart function. 
In facing a preclinical study in a big animal model (sheep) additional factors that 
condition the design of the solution must be taken into account. The most relevant ones 
are the size of the patch, the number of the cells to be transplanted, and the timing of 
pre-implant seeding and in vitro culture of the cells in the patch. The dimension of the 
patch designed for this study (5x5 cm) is related to the size of the infarct model created 
by surgical procedure (coronary artery branch ligations) in adult sheep [19,36], and the 
number of cells to be transplanted and the pre-implant culture time have followed 
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previous experience [18]. Taken together, these circumstances impose stringent 
requirements on the design of the patch: it must be able to lodge those numbers of cells, 
these must seed and distribute uniformly across the patch in 24 h, and the whole patch 
must be rapidly vascularized throughout after implantation, to keep the seeded cells 
alive. In the present work we address these questions, related to the design and 
implementation of a biohybrid patch for use in an infarcted sheep heart. 
 
2. Materials and methods 
2.1. Preparation of the scaffolds 
Scaffolds of polyethyl acrylate (PEA) with interconnected spherical pores were 
prepared following a porogen-template leaching method as described in [37, 38]. 
Briefly, poly(methyl methacrylate) microspheres (PMMA; Colacryl dp 300) of known 
size, 130 ± 20 μm, were sintered between two plates in order to obtain a porogen 
template. A monomer solution was prepared by mixing ethyl acrylate (EA; 99%, 
Sigma-Aldrich) with 2 wt% ethyleneglycol dimethacrylate (EGDMA; 98%, Sigma-
Aldrich) as crosslinker and 1 wt% benzoine (98%, Scharlau) as initiator, stirred and 
injected into the porogen template. The filled template was then placed between two 
glass plates, polymerized under a UV source for 24 h, and post-polymerized in an oven 
at 90˚C for another 24 h. The template was removed by soxhlet extraction for 24 h with 
acetone (Scharlab). Afterwards, a gradual solvent exchange to water was performed to 
avoid the collapse of the obtained scaffolds due to the fast evaporation of acetone. 
Finally, the 1 mm-thick PEA scaffolds obtained were dried under vacuum at 40ºC until 
constant weight, and cut as small discs of 8 mm diameter for in vitro assays. The 
obtained samples were sterilized with a 25 kGy dose of gamma irradiation in a 
60
Co 
source (Aragogamma, Barcelona, Spain) before use. 
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2.2. SAPs preparation and filling of the scaffolds 
The self-assembling peptide (SAPs) RAD16-I solution (PuraMatrix™ 1% (w/v), BD 
Biosciences) was employed as a filler hydrogel in the PEA scaffolds’ pores. The 
viscous stock solution was sonicated for 30 min at 25ºC applying 30 W in a Bandelin 
bath, diluted with water (extra pure, Scharlau) up to 0.3% (w/v) and vortexed (Elmi 
SkyLine) to ensure homogeneization. In one series of scaffolds, the SAP solution and 
the cells were simultaneously incorporated to the scaffolds; these will be hereafter 
called 1-step loaded scaffolds (Fig. 1a). In a second series of scaffolds (hereafter 
referred to as 2-steps loaded, Fig. 1b) the SAP was loaded as a 0.15% (w/v) solution 
with the help of some vacuum, as in [19, 39]; more precisely, the scaffold was placed 
(folded if necessary) in a large syringe, the aqueous SAPs solution was loaded, and the 
air removed. Next, maintaining the luer taper of the syringe sealed, the peptides solution 
was forced to penetrate in the scaffold by performing repeated strokes until it was 
completely wet.  
 
2.3. Seeding of ASCs and pre-culture of the biohybrids 
Adipose-tissue derived stem cells (ASCs) of subcutaneous fat tissue biopsies were 
obtained from the mediastinal fat tissue of female Ille de France sheep and isolated 
according to [12]. The adhered cells were incubated at 37ºC in a humidified atmosphere 
with 5% CO2 in minimum essential medium alpha (α–MEM) supplemented with fetal 
bovine serum (FBS; 10%), L-Glutamine (2 mM), penicillin (10 U/ml), streptomycin (10 
mg/ml), gentamicin (10 mg/ml) (all products from Gibco/Invitrogen) and plasmocin (5 
µg/ml, Invivogen, ant-mp) to avoid mycoplasma contamination. The cells were allowed 
to proliferate in culture flasks until passage 6, then harvested by trypsinization (0.25% 
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Trypsin-EDTA, Gibco/Invitrogen) and resuspended in a 10% sucrose (Sigma-Aldrich) 
aqueous solution (instead of culture medium, to avoid the SAPs gelling upon their 
contact) at densities of 5 and 10∙10
6
 cells/ml to be used in the two series of scaffolds. 
10
5
 cells were seeded in each scaffold having a diameter of 8 mm in a 48-well tissue 




 of scaffold. In the 2-step loaded 
scaffolds, the 10
5
 cells were seeded in a 20 μl aqueous droplet after the vacuum helped 
incorporation of the 0.15% (w/v) SAPs solution. For the 1-step loaded scaffolds, the 
initial 0.3% (w/v) SAPs solution was half diluted with the cells-sucrose suspension and 
20 μl of the resulting 0.15% (w/v) SAPs solution containing the 10
5
 cells was 
incorporated at once. 
The cell seeding was performed by two different methods: in a subset of samples, the 20 
μl cells (or cells+SAPs) droplet was seeded onto the upper-surface of the scaffolds, and 
in the other, the droplet was injected within the pores of the scaffolds making use of a 
Hamilton syringe. 
After the encouraging results, in terms of better cells distribution within the pores, 
obtained in a previous work [19] with a dynamic seeding as compared to a static one. 
Two dynamic methods were compared here: half of the scaffolds were smoothly shaken 
(25 rpm, 30 min) after the seeding in a Titramax 101 shaker (Heidolph instruments, 
Germany) and the remaining were centrifuged (600 rpm, 5 min) in a centrifuge 5804 
eppendorf device. Next, 300 μl more of culture medium were carefully added to each 
well to gel the peptides and entrap the cells, and cells were incubated at 37°C in a 
humidified atmosphere under 5% CO2 for 24 h. 
Each one of the 8 resulting experimental groups (1-step or 2-step loaded scaffolds, 
either seeded on their surfaces or by internal injection, and shaken or centrifuged before 
culture) consisted in three 8 mm-diameter replicas. They were subsequently 
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2.4. Biological characterization of the biohybrids 
After 24 h culture, the biohybrids were processed for fluorescence staining. Samples 
were rinsed with 0.1 M phosphate buffered saline (PBS; pH 7.4) and fixed for 15 min in 
4% paraformaldehyde (Panreac). After 30 min permeabilization with 10% fetal bovine 
serum and 0.1% triton X-100 in PBS, samples were incubated for 60 min in the selective 
F-actin stain Phalloidin Bodipy FL (Invitrogen) at a dilution of 1:200 in 0.1% BSA-PBS 
at room temperature and mouse monoclonal anti-vimentin (v6630, Sigma) overnight and 
incubated for 1 h with Alexa fluor goat anti-mouse 647 (A21236, Invitrogen)The 
samples were rinsed in PBS and then stained 5 min with 10 µg/mL DAPI (4',6-
diamidino-2-phenylindole, Sigma, 1:5000). Afterwards, the samples were cryoprotected 
by immersion in 0.1 M PBS at pH 7.5 containing 30% sucrose and included in OCT. 50 
μm-thick sections were obtained by using a cryostat (Leica, CM 1900), collected onto 
superfrost slides and rinsed with PBS. The slices were mounted on glass slides using 
Fluoromount-G™ (F4680, Sigma-Aldrich), and examined to collect fluorescent images 
under an epifluorescence (Leica DM6000) or confocal laser scanning microscope 
(CLSM; FV 1000, Olympus). 
 
2.5. Image processing 
For cell quantification, DAPI labelled cell nuclei were counted in three images taken 
under the fluorescence microscope before the scaffolds’ cutting, and corresponding each 
to 0.004 cm
2
 per each experimental group; the number of cell nuclei per unit area was 
obtained from these quantifications. To further evaluate the invasibility of the scaffolds 
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by the ASCs, the expression of F-actin (filamentous actin) in the cytoskeleton was 
quantified together with the DAPI labelling to determine the percentage of image area 
covered by cells. The mean cell surface area gave an idea of cells spreading and 
attachment in each case. All image processing and analysis were done using an in-house 
software developed under MATLAB R2006a (The MathWorks, Inc., Natick, MA). 
 
2.6. Scale-up and characterization of large biohybrids 
To set up the assembly of the biohybrids in the final dimensions following the best 
conditions found in vitro, large 5x5x0.1 cm
3
 PEA scaffolds were firstly prepared 
following the fabrication methodology explained above. To validate such protocol for 
large patches and ensure a homogeneous and high porosity and pores’ interconnections, 
bare scaffolds were examined by scanning electron microscopy (SEM) in a JSM 6300 
(JEOL Ltd., Tokyo, Japan) device, previously sputter-coated with gold, at 15 kV of 
acceleration voltage and 15 mm of working distance. The scaffolds were fractured in 
liquid nitrogen in order to obtain surface and transversal images. The proposed SAPs 
injection protocol and their gelling inside the pores upon the addition of culture medium 
was checked in large scaffolds by congo red 0.1% (w/v) aqueous solution (Fischer 
Scientific) staining for 20 min followed by 30 min of rinsing with water and 
macroscopical observation. 
The scaffold+SAPs+ASCs assembly protocol giving the best results in terms of 
invasion and homogeneous distribution of the cells in small biohybrids was translated to 
the large patches: the scaffolds were pre-loaded with the peptide solution, next seeded 
internally with a Hamilton syringe and smoothly shaken for 30 min at 80 rpm, and 
finally cultured for 24 h before analysis. After expansion and trypsinization, ASCs were 






cells were seeded per SAPs pre-loaded scaffold, distributed in 50 uniformly spaced 
injections of 50 µl each. 
After a 24 h culture, slices of the patches were analyzed by immunocytochemistry and 
confocal microscopy as described above, and by scanning electron microscopy in a SEM 
Hitachi S-4800 device. The samples were rinsed in 0.1 M PBS at pH 7.5 and fixed in a 
2% paraformaldehyde and 2.5% gluteraldehyde solution. The samples for SEM were 
post-fixed with 1% OsO4 (Aname, 19112) and dehydrated in serial ethanol (30, 50, 70, 
96 and 100%); next, they were dried using liquid CO2 (critical point values: 328ºC, 1100 
psi; Autosambri 814, Rockville, MD, USA) and coated with gold to be observed. 
 
2.7. Statistical analysis 
All values were expressed as mean ± standard deviation (SD) and analyzed statistically 
using a two-tailed Student’s t-test. The level of significance was set at p<0.05. 
 
3. Results 
3.1. Scale-up of the fabrication procedures to implantable large biohybrids 
Fig. 2a and 2c shows macroscopical and SEM images, respectively, of 5x5 cm
2
 PEA 
scaffolds, fabricated with the procedure employed previously for small scaffolds, but 
with special care on the uniform sintering of the porogen template and on the handling 
of the swollen scaffolds during the rinsing of the porogen. The obtained scaffolds 
showed interconnected spherical pores with pore diameters around 130 ± 20 µm, 
leading to a bulk porosity of 80.8±3.5%. They were flexible and adaptable to curved 
surfaces such as the myocardium. 
The SAPs filling procedure employed for the smaller samples was also valid for the 
large scaffolds: their elastomeric nature allows their rolling and folding inside a syringe 
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and successive stroked of its piston force the viscous peptide solution to penetrate into 
the pores. Fig. 2d shows the SAPs filling in the scaffold’s pores under cryoSEM, which 
appears as stretched-out fibers formed as water sublimates. The peptides solution 
successfully gels in situ within the pores of large scaffolds when in contact with culture 
medium, and the β-sheet structures stain red with congo red (Fig. 2b).  
 
3.2. Cell viability and distribution after the different seeding procedures in small 
biohybrids 
The effectiveness of the eight different seeding procedures chosen was studied after 24 
h culture. Fig. 3 shows the distribution of cell nuclei (stained with DAPI) under the 
fluorescence microscope. In the 1-step loaded and internally seeded scaffolds, the cells 
were concentrated in the vicinities of the injection point, as was also the case in those 
seeded on top of the surface in one step; few cells were able to migrate through the 
scaffolds’ pores and the non-attached leftover was lost. None of both dispersion 
methods (shaking or centrifugation before culture) helped to better distribute the cells 
within the scaffolds’ pores. Contrarily, when cells were seeded after a SAPs pre-load (2-
step loaded scaffolds), they were able to diffuse from the injection point, more when 
cells were seeded internally than on the surface; they invaded the whole available 
volume of the scaffolds. Both dynamic dispersion methods were equally effective in 
achieving rapid cell diffusion through the peptide filler.  
Next, a more thorough study was undertaken of the following factors: i) the effect of the 
SAPs solution on the efficiency of cell seeding, ii) the seeding points of the cells, either 
internal or superficial, and iii) the dynamic conditions to enhance cell diffusion before 
incubation.  
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The 1-step and 2-step loaded scaffolds, both seeded in their core with a Hamilton 
syringe and shaken before incubation, were compared to understand the role of SAPs 
during the seeding. The confocal microscopy images of longitudinal slices of such 
scaffolds after the immunocytochemistries (Fig. 4) confirm that when SAPs and cells 
are incorporated simultaneously the cells are retained in the peptide solution at the site 
of injection (a, b, taken at the injection site), whereas, when cells are seeded following 
the prior SAPs loading, they invade the scaffold and distribute homogeneously 
throughout it (c, d, representative of the whole scaffold). Interestingly, once lodged 
within the pores (24 h), the cells seem to attach to the PEA hydrophobic surface rather 
than remain suspended in the SAPs hydrogel (see the detail, e, f). In 1-step loaded 
scaffolds the cells maintained a spherical morphology, whereas in 2-step loaded ones 
cells appeared more elongated, indicative of the adhesion to the material surface. 
The viable cells of these 1-step and 2-step loaded scaffolds were next quantified by 
image analysis. The DAPI labelled cell nuclei yielded the number of cells per unit area, 
which increases 3-fold when the cells are incorporated after the peptide solution has 
been loaded in the inner pores, Fig. 5a. The F-actin (filamentous actin) staining with 
phalloidin allowed defining the area covered by cytoskeleton and . the mean cell surface 
area, calculated as the area covered by the cells divided through the number of cell 
nuclei (Fig. 5b). the first quantity  was considerably larged in 2-step loaded scaffolds, 
although the cell area was approximately the same with both procedures analyzed, in 
spite of their rather different morphology. 
Next, 2-step loaded scaffolds seeded either internally or on top of the surface, and 
shaken before incubation, were compared by immunocytochemistry and confocal 
microscopy to determine the depth to which cells diffuse through the peptide solution 
before being entrapped upon its gelation. The images of transversal cuts (Fig. 6) show 
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that only some of the cells seeded on the surface can penetrate, only 50 µm inwards the 
scaffold (a, b), whereas the rest are lost. By contrast, those injected internally are well 
distributed throughout the scaffold thickness (c, d).  
In 2-step loaded scaffolds seeded internally no differences were found between the two 
dynamic (shaking and centrifugation) seeding protocols proposed, insofar as both 
helped to distribute sufficiently the cells (figure not shown). It must be remarked that 
the application of some cell-dispersing protocol before the SAPs gelling and consequent 
cell entrapment is crucial, as was demonstrated in [19] against a conventional (static) 
seeding. 
 
3.3. Translation of the assembly protocol to large biohybrids for their implantation in a 
sheep model 
The best results produced by the culture of small discs were those of the 2-step loaded 
scaffolds, seeded internally with a Hamilton syringe and smoothly shaken (or 
centrifuged) before incubation; such small format biohybrids hosted in their pores the 
highest and most uniformly distributed cell population. These same steps were then 







 cells, suspended in 2.5 ml of sucrose supplemented aqueous 
medium, were incorporated to large 5x5x0.1 cm
3
 scaffolds previously loaded with the 
SAPs solution, with 50 equally spaced injections of 50 μl each, which correspond to 1 
internal injection per 0.5 cm
2
 of external surface (as in the small discs, where they had 
proved to spread over such an area). Next, the biohybrids were shaken horizontally at 80 
rpm for 30 min at 37ºC and incubated. After 1 day, they were analyzed to find out their 
state just before a hypothetical implantation in infarcted myocardium. Under confocal 
microscopy (Fig. 7) it was possible to observe that the ASCs were homogenously 
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distributed throughout the entire scaffold and tended to attach to the PEA trabecules 
establishing cell-cell contacts, rather than remaining suspended and isolated within the 
gel. Similar results were found by SEM (Fig. 8), although the preparation procedure is 
quite invasive and a non-negligible fraction of cells was lost from each slice: cells were 




The purpose of the present study was to set a methodology to determine an effective 
way to build-up large implantable byohibrid patches, fixing the different choices 
available to combine their three components: scaffold, peptide gel, and cells. The 
variables under study were: the manner and sequence for the incorporation of the 
peptide solution and the cells, the way to seed the cells in the scaffold, and the 
subsequent dynamic conditions before their incubation to achieve the greatest invasion 
and most uniform cell distribution within the construct. The alternative choices were 
first studied in small-sized biohybrids, and the selected options were then scaled-up to 
establish a protocol to prepare and assemble the large biohybrid patches for their 
subsequent implantation in the infarcted sheep.  
The need to have a large patch uniformly colonized by cells 24 h before surgery 
determined the main design options for the construct: the use of a filler hydrogel inside 
the pores of a patch with a highly regular pore architecture, produced by an opal-like 
porogenic template. It was argued that the large number of cells hosted in the patch 
could only be viable if the pore sizes of the scaffold allowed for a rapid ingrowth of 
microcapillaries when implanted, and it was judged that only a template-based 
manufacture of the scaffold, using a sintered template made of regular-sized spherical 
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microbeads, could ensure the necessary control over pore size and distribution. Other 
porogenic techniques lead to less controllable porous structures that cannot ensure 
perfect connectivity and size of the pores. Furthermore, it was advanced that a soft 
hydrogel filling the pores of the scaffold would constitute a medium improving cell 
spreading throughout the scaffold, thus permitting a fast and uniform cell colonization 
of the implantable structure. These basic hypotheses were confirmed by the results of 
our study. As several works have underlined [40-42], the microstructure of the scaffolds 
in tissue engineering is critical to ensure the hosting of a high enough cell density, allow 
cell migration, diffusion of nutrients and metabolites, new tissue growth and 
vascularization.   
The SAPs solution proved to be an excellent diffusion medium for the cells, provided 
that it was incorporated within the scaffold’s pores prior to the seeding (2-step loaded 
scaffolds). In the hours following the seeding, ASCs first migrate through the hydrogel 
and then attach to the PEA hydrophobic trabecules in an extended conformation with 
numerous cell-cell contacts. When cells were seeded simultaneously with the peptide in 
a specific location of the scaffold (1-step loaded scaffolds) the cells were only able to 
colonize the vicinities of the point where they had been seeded.  
The internal seeding of the cells (injected with a Hamilton syringe) into the scaffold 
gave much better results than a seeding on top of the surface of the scaffold, because in 
this latter case those cells that have not been able to invade the three-dimensional 
structure (especially if they have been seeded simultaneously with the peptide solution) 
are dragged away when the culture medium is added, and are consequently lost. Before 
the gelling of the peptide solution upon the addition of culture medium, and the 
consequent entrapment of cells, the mechanical assistance to cell spread represented by 
shaking or centrifuging greatly contributed to the uniform distribution of the cells 
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throughout the construct. This had already been identified in a previous work [19] as 
advantageous when compared with a static seeding, and the results obtained here reveal 
that such mechanical assistance can be performed by any means available (shaker, 
centrifuge) without significant differences in its outcome, at least in the range of the 
parameters tested here. 
These observations, gained from the experiments on small scaffolds samples, resulted in 
a biohybrid assembly method consisting in the following steps: 1) a pre-loading of the 
scaffold with the peptide solution with the help of syringe vacuum to force the viscous 
solution to penetrate into the pores of the hydrophobic scaffold, 2) the injection of the 
cell suspension within the filled scaffolds’ pores, and 3) a smooth shaking of the 
biohybrid to distribute the cells before the peptide solution was gelled by adding culture 
medium, and 4) subsequent incubation of the construct. 
Next, this assembly protocol was scaled-up to the needs of the large 5 X 5 cm
2
 scaffolds 
intended as myocardial patches for the preclinical study.  
The transition from the manufacture of small scaffolds to that of large format ones 
posed specific technical problems. Achieving a uniform sintering of the microbeads 
throughout the large porogen template is critical to guarantee the homogeneity of the 
porous structure of the ensuing scaffold, especially the pore interconnectivity. 
Furthermore, large scaffolds require a much more careful handling when swollen in 
solvents during the successive rinsings to obtain one-piece non-defective structures. A 
quality check to control these aspects had to be introduced, based on the inspection of 
SEM images of the structures obtained in different selected spots of the large patches.   
As regards the cell seeding, these large scaffolds required multiple, uniformly 
distributed, injection sites with a Hamilton syringe. To scale-up the results obtained 
from the experiments on the smaller samples, the area of the large patch was divided 
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into units of the same area as the smaller samples, where it had been established that 
uniform cell distribution could be achieved in 24 h with the selected protocol. This 
resulted in a number of 50 injections uniformly spaced through the large scaffold.  Once 
the cells were seeded, a mechanically assisted dispersion greatly helped the uniform 
colonization of the construct. Both methods here studied were equally effective with the 
small samples; nonetheless, in view of the technical limitations facing centrifugation of 
large biohybrids, the simpler shaker-assisted protocol was finally selected.  
 
5. Conclusions 
An effective protocol for assembling large biohybrid patches consisting in an 
elastomeric scaffold with a peptide-gel filling entrapping ASCs has been established. 
The alternative options in the way to achieve this goal have been settled with different 
experiments, and specific difficulties are discussed related to the fabrication of large 
uniform scaffolds with a high, interconnected porosity, their manipulation in the 
different stages, and the incorporation of the peptide solution and a high concentration 
of cells homogeneously distributed. The assembly protocol of these large biohybrid 
patches consisted in the incoporation of the peptide solution into the scaffold’s pores, 
the injection of the cells in different selected locations, their dispersion by shaking prior 
to the gelling of the peptide hydrogel, and the incubation of the hybrid construct. This 
sequence ensures that after a 24 h in vitro culture such biohybrids host a large number 
of viable cells uniformly distributed throughout the large area of the patch, and are 
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